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Purpose: Circulating acylated ghrelin concentrations are associated with altitude-induced anorexia in laboratory 23 
environments, but have never been measured at terrestrial altitude. This study examined time course changes in 24 
appetite, energy intake, body composition and ghrelin constituents during a high altitude trek. Methods: Twelve 25 
participants (age: 28(4) years, BMI: 23.0(2.1)kg.m-2) completed a 14-day trek in the Himalayas. Energy intake, 26 
appetite perceptions, body composition, and circulating acylated, des-acylated and total ghrelin concentrations 27 
were assessed at baseline (113m; 12 days prior to departure) and at three fixed research camps during the trek 28 
(3619m, day seven; 4600m, day 10; 5140m, day 12). Results: Relative to baseline, energy intake was lower at 29 
3619m (P=0.038) and 5140m (P=0.016) and tended to be lower at 4600m (P=0.056). Appetite perceptions were 30 
lower at 5140m (P=0.027) compared with baseline. Acylated ghrelin concentrations were lower at 3619m 31 
(P=0.046) and 4600m (P=0.038), and tended to be lower at 5140m (P=0.070), compared with baseline. Des-32 
acylated ghrelin concentrations did not significantly change during the trek (P=0.177). Total ghrelin 33 
concentrations decreased from baseline to 4600m (P=0.045). Skinfold thickness was lower at all points during the 34 
trek compared with baseline (P≤0.001) and calf girth decreased incrementally during the trek (P=0.010). 35 
Conclusions: Changes in plasma acylated and total ghrelin concentrations may contribute to the suppression of 36 
appetite and energy intake at altitude but differences in the time course of these responses suggests that additional 37 
factors are also involved. Interventions are required to maintain appetite and energy balance during trekking at 38 
terrestrial altitudes.   39 
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Abbreviations  42 
AG:DG Acylated ghrelin to des-acylated ghrelin ratio 
AMS Acute mountain sickness 
ANOVA Analysis of variance 
BMI Body mass index 
CAS Composite appetite score 
GOAT Ghrelin-O-acyltransferase 
ISAK International Society for the Advancement of 
Kinanthropometry 
LLS Lake Louise Score 
MoDREC Ministry of Defence Research Ethics Committee 
RPE Rating of perceived exertion 
SD Standard deviation 
SE Standard error 
SpO2 Arterial oxygen saturations 
VAS Visual analogue scales 
 43 




Acute exposure to hypoxic environments has been demonstrated to supress appetite and energy intake (Armellini 46 
et al. 1997; Matu et al. 2017; Wasse et al. 2012; Westerterp et al. 2000). This effect appears to be maintained 47 
during prolonged sojourns to high altitude, which results in significant decreases in body mass, of which greater 48 
than 50 % is from fat-free mass (Rose et al. 1988; Sergi et al. 2010). These declines in lean mass will likely lead 49 
to a drop in physical capabilities at altitude (Sergi et al. 2010), which can have deleterious implications for 50 
individuals ascending to high altitude. A better understanding of the time course of these changes during a trek, 51 
as well as the mechanisms involved, is required to develop guidance for those travelling to high altitudes. 52 
 Over the past twenty years, changes in the circulating concentrations of gastrointestinal hormones and 53 
leptin have been implicated as potential mechanisms for the alterations in appetite and energy intake at altitude. 54 
However, although several hormones such as pancreatic polypeptide (Riepl et al. 2012), leptin (Sierra-Johnson et 55 
al. 2008), glucagon-like-peptide-1 (Snyder et al. 2008) and total ghrelin (Benso et al. 2007; Riepl et al. 2012; 56 
Shukla et al. 2005) have been measured in response to terrestrial altitude exposure, the findings remain equivocal. 57 
One major limitation of the current research is the measurement of total ghrelin concentrations at altitude, rather 58 
than the constituent components of acylated and des-acylated ghrelin which have opposing effects on appetite 59 
regulation (Fernandez et al. 2016). The differentiation of ghrelin constituents in response to terrestrial altitude is 60 
imperative as acylated ghrelin has been found to be particularly responsive to hypoxic exposure in a laboratory 61 
environment with decreases in this hormone correlated with a reduction in appetite (Bailey et al. 2015) and energy 62 
intake (Wasse et al. 2012). Furthermore, recent evidence suggests that des-acylated ghrelin may inhibit the 63 
orexigenic effects of acylated ghrelin (Fernandez et al. 2016), which further emphasises the need to measure both 64 
hormones as well as the ratio between the two (Al Massadi et al. 2014). It seems feasible that the measurement of 65 
total ghrelin in previous research (Benso et al. 2007; Debevec et al. 2014; Riepl et al. 2012) may have masked 66 
changes in acylated and des-acylated ghrelin, which may explain the lack of association between changes in 67 
appetite and circulating ghrelin concentrations at altitude.  68 
Although circulating total ghrelin concentrations have been extensively investigated in response to 69 
hypoxic exposure (Benso et al. 2007; Debevec et al. 2014; Debevec et al. 2016; Mekjavic et al. 2016; Riepl et al. 70 
2012; Shukla et al. 2005), the investigation of acylated ghrelin is currently limited to four studies, all of which 71 
lasted for ≤ 7 h and were all conducted in normobaric environments (Bailey et al. 2015; Matu et al. 2017; 72 
Morishima and Goto 2016; Wasse et al. 2012). Although laboratory studies of this nature are valuable to gain 73 
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greater mechanistic understanding, further field studies are required to assess the combined effects of trekking, 74 
gradual ascent and other environmental stimuli such as cold exposure which occur during real life ascent to high 75 
altitude. The measurement of acylated and des-acylated ghrelin during ascent to terrestrial altitude is vital to 76 
understand the changes that occur during a real-world environment and the importance of these changes as a basis 77 
for the development of future interventions. The lack of investigation into the constituents of total ghrelin to date 78 
is likely due to the complexities of the necessary chemical preparation required to prevent the degradation of the 79 
analytes (Hosoda et al. 2004), which is particularly difficult to achieve in an extreme field environment.  80 
 The purpose of this study was to investigate the effects of a high altitude trek to 5300 m on appetite, 81 
energy intake and body composition responses in healthy men and women, with a further focus on circulating 82 
acylated and des-acylated ghrelin concentrations as mechanistic variables. These data provide novel insights into 83 
the time course of changes in appetite, energy intake and body composition during a real-life ascent to high 84 
altitude. This study also provides a better understanding of the mechanisms responsible for altitude-induced 85 
anorexia, representing the first investigation of acylated ghrelin and des-acylated ghrelin at terrestrial altitude. We 86 
hypothesised that exposure to increasingly high altitudes would suppress appetite, circulating acylated ghrelin 87 
concentrations and energy intake, which would be associated with a reduction in lean and total body mass. 88 




Participants. This study was conducted according to the guidelines laid down in the Declaration of 91 
Helsinki and all procedures were approved by the Ethics Advisory Committee at Leeds Beckett University and 92 
the Ministry of Defence Research Ethics Committee (MoDREC; protocol number 624). Twelve members (nine 93 
male, three female) of the British Military volunteered to participate in this study. Informed consent was obtained 94 
from all participants included in the study. All participants were non-smokers, had no known disease, allergies or 95 
intolerances, and had not been to an altitude over 1000 m for at least 3 months. All participants were physically 96 
fit and could run 2.4 km on a treadmill at a 2 % gradient in under 13 minutes 37 seconds in accordance with 97 
military requirements. The physical characteristics of participants (mean (SD)) were as follows: age 28 (4) years, 98 
body mass 71.3 (10.3) kg, body mass index (BMI) 23.0 (2.1) kg.m-2. 99 
Study design. This study represents part of the ‘British Services Dhaulagiri Medical Research 100 
Expedition’ which took place in March – May 2016 (Mellor et al. 2017). In April 2016, participants in the present 101 
study travelled from the UK to Nepal and completed a 14-day trek around the Dhaulagiri circuit in the Himalayas. 102 
Travel from the UK to Nepal lasted for one day and participants were in Nepal for three days prior to starting the 103 
trek. The trek commenced from Darbang (~1100 m), peaked on day 11 at the French Pass (~5300 m) and ended 104 
on day 14 at Marpha (~2700 m). Pre-planned rest days were included at fixed camps at 3619 m (Camp 1; day 105 
seven), 4600 m (Camp 2; day 10) and 5140 m (Camp 3; day 12). Participants walked a mean distance of 8.2 106 
km.day-1 with a mean elevation gain of 471 m.day-1 whilst carrying a day pack weighing ~ 5 kg. Further 107 
information about the ascent profile and trek characteristics has been published elsewhere (Mellor et al. 2017). 108 
Data collection took place at baseline (113m; 12 days prior to departure from the UK) and at each fixed camp. On 109 
the day preceding data collection at camp 1, camp 2 and camp 3 participants walked 4.3 km, 4.3 km and 9.1 km 110 
and gained an elevation of 512 m, 528 m and 540 m, respectively. All trekking on these days was completed by 111 
5pm. All participants wore the same type of clothing throughout the trek and experienced the same degree of cold 112 
exposure. Baseline measurements were collected in the laboratories at Leeds Beckett University and the measures 113 
at each camp were collected in a designated research tent. At the time data was collected ambient temperatures in 114 
the laboratory and research tents were 19.8 °C, 4.9 °C, 1.2 °C and -6.4 °C at baseline, 3619 m, 4600 m and 5140 115 
m, respectively. All participants remained rested on the day of testing. Participants were staggered for the 116 
collection of all measurements between 7 am and 10 am, with each participant having their measures taken at a 117 
consistent time on all occasions and after an overnight fast of at least 10 h. 118 
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Food Provision. Throughout the trek all food and fluid was available ad libitum, and was provided by 119 
Nepalese cooks and staff who accompanied the trekking team. Typical foods offered at each meal were as follows: 120 
Breakfast – cereals, porridge, omelette, pancakes; Lunch – noodles, meats, soup, beans, vegetables, fruit; Dinner 121 
– curry, pasta, pizza, potatoes, dumplings, cheese, vegetables; Snacks – chocolate bars, biscuits, cake, fruit. At all 122 
meals participants were given more than one option and thus could decide what they wanted to eat. The mean 123 
(SD) macronutrient composition of the food consumed during the trek was 49.0 (6.6) % carbohydrate, 36.3 (6.2) 124 
% fat and 14.7 (2.6) % protein, respectively.  125 
Food intake. Energy intake was assessed at baseline via a 24-hour dietary recall interview by an 126 
experienced researcher (Academic Associate of the Sport and Exercise Nutrition Register) using the multiple-pass 127 
approach (Guenther et al. 1997). In addition to collecting dietary intake information, this approach was used to 128 
demonstrate the level of detail required from the participants when completing a food diary during the trek. All 129 
participants completed a food diary on the day preceding each fixed camp and this process was monitored and 130 
verified by the same experienced researcher throughout the trek.  Although there are acknowledged limitations of 131 
self-reported dietary intake methods (Hill and Davies 2001), the oversight of food diaries by the researcher present 132 
on the trek ensured accurate completion of all food diaries. Food intake was monitored during the day before each 133 
fixed camp to consider acute dietary changes when interpreting the data for fasted appetite ratings and blood 134 
samples at the fixed camps. The palatability of each meal consumed was measured using 100 mm visual analogue 135 
scales (VAS) with the anchors “the worst taste that I have ever experienced” and “the best taste that I have ever 136 
experienced” at each end of the scale. A mean palatability score was calculated for each day to control for any 137 
influence of palatability on food consumption. 138 
Appetite. Appetite perceptions were measured after an overnight fast at baseline and upon waking at 139 
each fixed camp using validated 100 mm VAS for hunger, satisfaction, fullness and prospective food consumption 140 
(PFC) (Flint et al. 2000). Using these scales, a composite appetite score (CAS) was calculated using the following 141 
formula: composite appetite score = ([hunger + prospective food consumption + (100 – fullness) + (100 – 142 
satisfaction)] / 4) (Stubbs et al. 2000). A higher value is associated with a greater appetite sensation and 143 
subsequently a stronger motivation to eat. In addition, the extent to which participants desired sweet, salty, 144 
savoury, and fatty foods was assessed using VAS anchored at each end with “yes, very much” and “no, not at all”. 145 
Acute Mountain Sickness, oxygen saturation and rating of perceived exertion. Acute mountain 146 
sickness (AMS) was assessed every morning and evening using the Lake Louise AMS (LLS) score (Roach et al. 147 
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1993); mild AMS was defined as LLS of ≥3 in the presence of a headache and severe AMS was defined as LLS 148 
of ≥6 in the presence of a headache. Arterial oxygen saturations (SpO2) were measured via a fingertip pulse 149 
oximeter (Nellcor™ PM10N; Medtronic, Minneapolis, MN) every morning and evening while the participants 150 
were resting in a seated position. Rating of perceived exertion (RPE) (Borg 1982) was recorded as the hardest 151 
exertion experienced during the day of trekking preceding each fixed camp, as used previously in similar 152 
environments (Mellor et al. 2014).  153 
Body composition. Participants were weighed at baseline and each fixed camp in a fasted state whilst 154 
wearing minimal clothing and no footwear. A portable multicomponent force plate (Kistler, Switzerland) was 155 
used and was stabilised on the mountain using specialised levelling feet (JVD Design & Automation Ltd, Leeds, 156 
UK). Skinfolds of the triceps, subscapular, biceps, iliac crest, supraspinale, abdominal, front thigh and medial calf 157 
were measured using calibrated Harpenden callipers (John Bull, British Indicators, West Sussex, UK) to the 158 
nearest 0.1 mm. The sum of skinfolds was calculated by the addition of each of the eight skinfold values in mm. 159 
Girth measurements of the waist and calf, as well as the upper arm in a relaxed and flexed state, were obtained 160 
using a steel anthropometric tape (Lufkin W606PM, Cooper Hand Tools, Tyne & Wear, UK) to the nearest 1 mm. 161 
All anthropometric assessments were conducted by one researcher who was trained by an individual accredited 162 
by the International Society for the Advancement of Kinanthropometry (ISAK). All measures were conducted in 163 
duplicate and in accordance with ISAK guidelines on the right side of the body. The coefficient of variation for 164 
skinfolds and girths was 2.2% and 0.4%, respectively.  165 
Blood sampling. Venous blood samples were obtained from an antecubital vein via venepuncture using 166 
a 21-gauge butterfly needle (Safety-Lok™; BD, Oxford, UK). Samples were collected at baseline and at all 167 
research camps with participants in a fasted state. One 4.9 mL pre-cooled EDTA monovette (Sarstedt, Leicester, 168 
UK) was used to obtain samples for the determination of plasma acylated and des-acylated ghrelin concentrations. 169 
Monovettes were pre-treated on the morning of testing, to prevent the degradation of acylated ghrelin, with 50µl 170 
of a solution containing p-hydroxymercuribenzoic acid, potassium phosphate buffer and sodium hydroxide 171 
(Hosoda et al. 2004). Immediately after filling, the tube was spun at 1500 x g for 10 minutes in a centrifuge 172 
(CompactStar CS4, VWR). Subsequently 1 mL of plasma was mixed with 100µl of 1M hydrochloric acid. This 173 
solution was then immediately frozen at either -20°C in a freezer (for baseline measurements) or within a dry 174 
shipper containing liquid nitrogen at <-80°C (at each fixed camp) before being transferred to a -80°C freezer at 175 
the university and stored until analysis. Plasma volume changes as a result of altitude exposure were not assessed 176 
during the trek because it is the absolute plasma hormonal concentrations that would determine the body’s 177 
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response at that specific time (Kargotich et al. 1998). However, to prevent any extraneous influences from postural 178 
changes, all blood samples were collected after the participant had been seated for at least 5 minutes (Fawcett and 179 
Wynn 1960). 180 
Blood analyses. Commercially available enzyme immunoassays were used to determine plasma 181 
concentrations of acylated and des-acylated ghrelin (SPI BIO, Montigny Le Bretonneux, France). To eliminate 182 
interassay variation, all samples from each participant were analysed on the same plate. In addition, all samples 183 
were analysed in duplicate and on the same day. The within batch coefficients of variation were 2.5% for acylated 184 
ghrelin and 2.4% for des-acylated ghrelin. Total ghrelin was computed via the addition of acylated and des-185 
acylated ghrelin concentrations. The ratio between acylated ghrelin and des-acylated ghrelin concentrations 186 
(AG:DG) was calculated as acylated ghrelin divided by des-acylated ghrelin, as previously described (Delhanty 187 
et al. 2015).  188 
Statistical analysis. Data are expressed as mean (SD) in text and tables and mean (SE) in figures to 189 
avoid distortion of the graphs. Diet records were inputted into Nutritics dietary analysis software (v1.8 for 190 
Windows; Nutritics, Dublin) to assess energy intake. All data were analysed using IBM SPSS statistics (v22.0 for 191 
Windows; SPSS, Chicago, IL). One way repeated measures analysis of variance (ANOVA) was used to assess 192 
altitude-based differences in SpO2, AMS scores, RPE scores, body composition measures, appetite perceptions, 193 
energy intake, fluid intake and plasma ghrelin concentrations. Significant effects were further explored using 194 
Student’s paired t tests. Effect sizes are presented as Cohen’s d and interpreted as ≤ 0.2 trivial, > 0.2 small, > 0.6 195 
moderate, > 1.2 large, > 2 very large and > 4 extremely large (Hopkins 2004). The Pearson product moment 196 
correlation coefficient was used to investigate relationships between variables at each altitude. The exclusion of 197 
participants reporting AMS did not alter the interpretation of the findings; subsequently all participants were 198 
included in the data analysis. Based on evidence that males and females exhibit similar appetite, energy intake 199 
and gut hormone responses to exercise- and diet-induced energy deficits (Alajmi et al. 2016), data from both 200 
genders were combined for analyses. The sample size used within this study was deemed sufficient to detect a 201 
significant difference in energy intake between altitudes. The anticipated effect size for a difference in energy 202 
intake was based on a similar previous study which investigated energy intake in individuals climbing at 203 
approximately 4500 m for 16 days (Armellini et al. 1997). Based on the effect size and an alpha value of 5 %, a 204 
sample size of 12 participants would generate a power >95 %. Calculations were performed using G*power (v3 205 




Measurements of SpO2, AMS, RPE, body composition, fluid intake and energy intake were successfully obtained 208 
from all 12 participants. One male participant withdrew consent for blood sampling at the research camps during 209 
the trek and one male participant did not complete the appetite perception measurements during the trek. 210 
Therefore, data is presented for 11 participants for plasma hormone concentrations and appetite perceptions.  211 
 212 
Oxygen saturations, acute mountain sickness and rating of perceived exertion. One way ANOVA 213 
revealed a main effect of altitude for SpO2 (P <0.001). Post-hoc analysis demonstrated lower SpO2 at each fixed 214 
camp compared with the previous location (baseline: 98.4 (0.9) %; 3619 m: 92.4 (2.5) %, P < 0.001, d = 3.19; 215 
4600 m: 83.5 (4.1) %, P < 0.001, d = 2.62; 5140 m: 79.8 (5.6) %, P = 0.007, d = 0.75). A positive diagnosis of 216 
mild AMS was reported in 50% of participants at some point during the trek. The first incidence of AMS occurred 217 
on the eighth day of the trek (the day after the first rest day; 4072 m). Incidence of AMS at the four fixed locations 218 
was as follows: baseline: zero participants; 3619 m: zero participants; 4600 m: two participants; and 5140 m: two 219 
participants. One way ANOVA revealed a significant effect of altitude for RPE (P < 0.001). Relative to 3619 m 220 
(11.8 (1.5)), RPE was significantly higher at 4600 m (13.3 (1.5), P = 0.009, d = 1.01) and relative to 4600 m RPE 221 
was significantly higher at 5140 m (16.5 (2.5), P = 0.003, d = 1.58). 222 
 223 
Energy and fluid intake. One way ANOVA revealed a significant effect of altitude for energy intake 224 
(P = 0.015). Relative to baseline, energy intake was significantly lower at 3619 m (P = 0.038, d = 1.05) and 5140 225 
m (P = 0.016, d = 1.00) and tended to be lower at 4600 m (P = 0.056, d = 0.82). There were no differences observed 226 
between research camps during the trek (all P ≥ 0.333, d ≤ 0.22) (Figure 1a).  227 
 One way ANOVA revealed a main effect of altitude for fluid intake (P = 0.029). Relative to baseline 228 
(2769 (1156) mL.day-1) fluid intake was significantly higher at 3619 m (4438 (1847) mL.day-1, P = 0.008, d = 229 
1.08) and 4600 m (4236 (2120) mL.day-1, P = 0.027, d = 0.86), but not significantly higher at 5140 m (3645 (2026) 230 
mL.day-1, P = 0.126, d = 0.53). There were no differences observed between camps (all P ≥ 0.266, d ≤ 0.29). 231 
One way ANOVA revealed a main effect of altitude for the daily palatability of food consumed (P = 232 
0.018). Relative to baseline, palatability was significantly higher at 3619 m (P = 0.030, d = 1.17). However, 233 
palatability was not different at 4600 m (P = 0.147, d = 0.66) or 5140 m (P = 0.509, d = 0.32) compared with 234 
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baseline. Palatability was significantly lower at 5140 m compared with 3619 m (P = 0.020, d = 0.97) and 4600 m 235 
(P = 0.013, d = 0.71) (Figure 1b).  236 
One way ANOVA revealed a main effect of altitude on the desire to eat salty (P = 0.025) and savoury (P 237 
< 0.001) foods, but not sweet (P = 0.604) or fatty (P = 0.354) foods. Relative to baseline (67 (12) mm), the desire 238 
to eat salty foods was significantly lower at 3619 m (41 (23) mm, P = 0.018, d = 1.42) and 5140 m (39 (27) mm, 239 
P = 0.024, d = 1.38), and also tended to be lower at 4600 m (45 (27) mm, P = 0.066, d = 1.09). There were no 240 
differences observed between camps (all P ≥ 0.159, d ≤ 0.22). The desire to eat savoury foods was significantly 241 
increased at 3619 m (70 (13) mm, P < 0.001, d = 2.41), 4600 m (67 (15) mm, P < 0.001, d = 2.03) and 5140 m 242 
(53 (19) mm, P = 0.011, d = 1.08) compared with baseline (33 (18) mm). In addition, the desire to eat savoury 243 
foods reduced significantly from 4600 m to 5140 m (P = 0.026, d = 0.79) with no difference observed between 244 
3619 m and 4600 m (P = 0.516, d = 0.23). 245 
 246 
Appetite perceptions. One way ANOVA revealed a main effect of altitude for CAS (P = 0.005). Post-247 
hoc analysis revealed that CAS was significantly lower at 5140 m compared with baseline (P = 0.027, d = 1.07), 248 
3619 m (P = 0.005, d = 1.19) and 4600 m (P = 0.05, d = 0.69). No other differences were observed between 249 
altitudes (all P ≥ 0.116, d ≤ 0.48) (Figure 1c).  250 
 251 
Plasma acylated and des-acylated ghrelin concentrations. One way ANOVA revealed a significant 252 
effect of altitude for plasma acylated ghrelin concentrations (P = 0.048; Figure 2a), plasma total ghrelin 253 
concentrations (P = 0.047; Figure 2d) and the AG:DG ratio (P = 0.046; Figure 2c). A main effect of altitude was 254 
not detected for plasma des-acylated ghrelin concentrations (P = 0.177; Figure 2b).  255 
 Relative to baseline, plasma acylated ghrelin concentrations were significantly lower at 3619 m (P = 256 
0.046, d = 0.25) and 4600 m (P = 0.038, d = 0.29), and tended to be lower at 5140 m (P = 0.070, d = 0.28). There 257 
were no differences observed between camps (all P ≥ 0.512, d ≤ 0.04; Figure 2a). Plasma AG:DG ratio decreased 258 
significantly from baseline to 3619 m (P = 0.034, d = 0.37), and tended to be lower than baseline at 4600 m (P = 259 
0.069, d = 0.23) and 5140 m (P = 0.070, d = 0.25). There were no differences observed between camps (all P ≥ 260 
0.362, d ≤ 0.15) (Figure 2c). Plasma total ghrelin concentrations decreased significantly from baseline to 4600 m 261 
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(P = 0.045, d = 0.36), however no other significant differences were observed between altitudes (all P ≥ 0.111, d 262 
≤ 0.31) (Figure 2d).  263 
 264 
Body composition. One way ANOVA revealed a significant effect of altitude for body mass (P < 0.001), 265 
sum of skinfolds (P < 0.001), calf girth (P = 0.010), waist girth (P = 0.016) and relaxed arm girth (P = 0.029), with 266 
no significant differences observed for flexed arm girth (P = 0.173) (Table 1).  267 
Body mass increased from baseline to 3619 m (P = 0.002, d = 0.18), decreased between 3619 m and 268 
4600 m (P < 0.001, d = 0.22) and did not change between 4600 m and 5140 m (P = 0.415, d = 0.03). Sum of 269 
skinfolds was lower at 3619 m (P = 0.001, d = 0.30), 4600 m (P < 0.001, d = 0.34) and 5140 m (P = 0.001, d = 270 
0.24) compared with baseline. There were no significant differences observed between each of the camps during 271 
the trek (all P ≥ 0.116, d ≤ 0.09).  272 
 Calf girth did not differ significantly between baseline and 3619 m (P = 0.127, d = 0.30), however was 273 
significantly decreased at 4600 m (P = 0.039, d = 0.44) and 5140 m (P = 0.008, d = 0.60) compared with baseline. 274 
Calf girth was also significantly lower at 4600 m compared with 3619 m (P = 0.031, d = 0.14), and tended to be 275 
lower at 5140 m compared with 4600 m (P = 0.069, d = 0.14). Waist girth did not differ between baseline and any 276 
of the three camps (all P ≥ 0.122, d ≤ 0.15), however was significantly lower at 5140 m than 3619 m (P < 0.001, 277 
d = 0.29) and 4600 m (P = 0.04, d = 0.13). Relaxed arm girth was significantly lower at 3619 m (P = 0.022, d = 278 
0.30) and 4600 m (P = 0.047, d =0.23) and tended to be lower at 5140 m (P = 0.073, d = 0.20) compared with 279 
baseline. There was a significant increase in relaxed arm girth between 3619 m and 5140 m (P = 0.047, d = 0.10), 280 
with no other differences observed between camps (all P ≥ 0.191, d ≤ 0.07).  281 
 282 
Correlations. There were no correlations observed at any altitude between energy intake and CAS (all r 283 
≤ 0.311, P ≥ 0.352). At 3619 m CAS tended to be associated with plasma acylated ghrelin (r = 0.603, P = 0.065) 284 
and total ghrelin (r = 0.626, P = 0.053) concentrations. Additionally, at 3619 m energy intake was significantly 285 
correlated with des-acylated ghrelin concentrations (r = 0.686, P = 0.029). At 4600 m CAS was significantly 286 
correlated with acylated ghrelin concentrations (r = 0.633, P = 0.049) and the AG:DG ratio (r = 0.667, P = 0.035). 287 






This study presents an assessment of the changes in appetite perceptions, energy intake, body composition, and 292 
ghrelin constituents throughout a trek to high terrestrial altitude. The findings demonstrate a reduction in energy 293 
intake and skinfold thickness during the trek, with a progressive reduction in appetite at increasing altitudes. This 294 
study provides the first investigation of acylated ghrelin and des-acylated ghrelin concentrations at terrestrial 295 
altitude and demonstrates a suppression of acylated- but not des-acylated ghrelin during the trek. These findings 296 
highlight the importance of measuring ghrelin constituents in addition to total ghrelin concentrations as small 297 
fluctuations in des-acylated ghrelin may mask changes in acylated ghrelin if only total ghrelin were to be 298 
measured. This phenomenon would have occurred at 3619 m in the present study as observed by a significant 299 
decrease in acylated ghrelin levels in the absence of any significant changes in des-acylated and total ghrelin 300 
concentrations. The findings from this study also demonstrate the need for interventions to maintain appetite 301 
during exposure to terrestrial altitudes, particularly above 4600 m.   302 
In the present study energy intake was reduced by 27 % (9326 kJ) at 3619 m, 22 % (9886 kJ) at 4600 m, 303 
and 27 % (9238 kJ) at 5140 m compared with baseline, which substantiates previous findings at similar altitudes. 304 
Armellini et al. (1997) observed a 29 % decrease in energy intake in individuals climbing at approximately 4500 305 
m for 16 days, whilst Aeberli et al. (2013) demonstrated a 32 % reduction in energy intake two days after rapid 306 
ascent to 4559 m. One study however, found that energy intake, as well as fat and muscle mass, could be 307 
maintained up to an altitude of 5050 m when a wide choice of palatable foods were available in a comfortable 308 
setting (Kayser et al. 1993). It may therefore be argued that the reduction in energy intake in the present study 309 
was caused by a lack of food availability and reduced palatability of food whilst trekking in a foreign country. 310 
However, at 3619 m, energy intake was significantly supressed compared with baseline while food was widely 311 
available and the mean palatability of the food consumed was significantly higher than baseline. These findings 312 
agree with those of Rose et al. (1988) who found a significant reduction in ad-libitum energy intake during a 313 
simulated ascent of Mount Everest, despite a variety of palatable foods being available. Despite the reduction in 314 
energy intake, fasting appetite perceptions were similar between baseline and 3619 m, which suggests a greater 315 
satiating effect of the energy consumed. This response was maintained at 4600 m but appetite perceptions 316 
decreased significantly at 5140 m despite consistent food intake. Observations during the trek suggested that 317 
participants were consciously trying to maintain energy intakes throughout the trek in an attempt to maintain 318 
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physical performance. This would support the observation that food intake was similar between the three camps 319 
but that appetite perceptions and the desire for foods decreased with increasing altitude. This mismatch between 320 
appetite perceptions and energy intake is further supported by the lack of correlation between the two variables at 321 
each altitude. The reduced palatability of the foods consumed at 5140 m also supports a reduction in appetite, and 322 
occurred despite the same ad libitum food provision throughout the trek. This effect accords with the findings 323 
from previous animal studies which suggest that hypoxia degrades the taste of food (Ettinger and Staddon 1982). 324 
Considering the significant suppression of appetite at 5140 m, it is unclear whether food intakes could continue 325 
to be maintained over a more prolonged period and targeted interventions to better maintain appetite above 4600 326 
m may be beneficial. 327 
From a mechanistic perspective, trekking to high altitude induced a suppression of acylated but not des-328 
acylated ghrelin concentrations, which resulted in a suppression of total ghrelin levels and the AG:DG ratio. 329 
However at 5140 m, the only altitude in which CAS was significantly supressed, no correlations were observed 330 
between any blood marker and CAS or energy intake. These findings suggest that appetite regulation during high-331 
altitude trekking may be influenced by other hormonal (e.g. leptin, glucagon-like peptide-1 and peptide YY 332 
(Debevec 2017)) and non-hormonal (e.g. taste degradation (Ettinger and Staddon 1982) potentially altering food 333 
reward (Berthoud 2006)) factors. Appetite regulation is a complex multifaceted system which involves the 334 
integration of a wide range of neuroendocrine and psychological factors (Murphy and Bloom 2006). Subsequently, 335 
appetite suppression at altitude is unlikely to be solely explained by the measurement of a single hormone. 336 
However, a better understanding of the neuroendocrine responses to high altitude trekking could be beneficial in 337 
the design of interventions to minimise appetite suppression at altitude. 338 
The reductions in fasted acylated and total ghrelin concentrations, the day after significantly reduced 339 
energy intakes compared with baseline measurements, are particularly interesting considering the evidence that 340 
ghrelin levels and appetite perceptions increase in response to reduced food intake at sea level (Alajmi et al. 2016). 341 
Furthermore, acylated ghrelin levels remained depressed during the trek despite reductions in body mass between 342 
3619 m and 4600 m and the established inverse relationship between body mass and ghrelin concentrations at sea 343 
level (Chen et al. 2009; Shiiya et al. 2002).  These observations suggest that the reductions in acylated and total 344 
ghrelin during this study were genuine effects of high altitude exposure rather than being secondary to any changes 345 
in food intake or body composition. Although these changes in ghrelin were small, they appear to be 346 
physiologically relevant as changes of this magnitude have previously been associated with reductions in appetite 347 
and energy intake in a laboratory environment (Bailey et al. 2015; Wasse et al. 2012). It would be beneficial for 348 
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future research to attempt to increase circulating plasma acylated ghrelin concentrations at altitude, in order to 349 
quantify these effects on appetite responses. Potential methods of accomplishing this include ghrelin infusion 350 
(Druce et al. 2005) or dietary interventions to manipulate ghrelin constituents (e.g. increased medium chain 351 
triglyceride intake as a substrate for ghrelin acylation (Kawai et al. 2017; Nishi et al. 2005)). 352 
The reasons for the observed suppression of acylated ghrelin at altitude are unclear. However, 353 
considering the lack of change in total ghrelin levels at 3619 m, it seems plausible that the post-translational 354 
acylation of ghrelin may have been inhibited during the early stages of the trek due to inhibited ghrelin-O-355 
acyltransferase (GOAT) activity or reduced availability of medium chain fatty acids as the substrate for acylation 356 
(Nishi et al. 2005). Alternatively, the reduction in both acylated ghrelin and total ghrelin at 4600 m suggests 357 
inhibited secretion of ghrelin from the P/D1 cells of the stomach (Kojima et al. 1999). A reduction in gut blood 358 
flow at altitude (Loshbaugh et al. 2006) has also been proposed to reduce ghrelin concentrations (Wasse et al. 359 
2012), however this concept has been disputed (Kalson et al. 2010; Mekjavic et al. 2016). The depression of 360 
acylated ghrelin levels prior to the depression of total ghrelin levels at the subsequent research camp suggests that 361 
acylated ghrelin may be a more sensitive measure of altered appetite signalling at altitude. Furthermore, the 362 
AG:DG ratio of >1 in the present study supports recent data that acylated ghrelin constitutes a much larger 363 
proportion of total ghrelin than previously thought (Delhanty et al. 2015) and demonstrates that preservation of 364 
this peptide can be achieved during field research in extreme environments.  365 
In accordance with previous research, considerable changes in body composition were observed during 366 
the trek. This includes a mean reduction in body mass of 2.3 kg in the three days between 3619 m and 4600 m, 367 
which was associated with significant decreases in calf girth despite very high levels of physical activity (mean 368 
distance walked: 8.8 km.day-1, mean elevation gain: 491 m.day-1). It seems likely that the reductions in body mass 369 
were not only caused by decreases in energy intake, but also by increases in energy expenditure due to the high 370 
altitude environment and high physical activity levels. Such decreases in body and muscle mass have been 371 
observed in previous altitude research (Benso et al. 2007; Rose et al. 1988; Shukla et al. 2005; Westerterp et al. 372 
2000) and it is likely that these losses would impair physical performance in these environments (Sergi et al. 373 
2010). The further reductions in calf girth between 3619 m and 5140 m also aligns with previous research (Rose 374 
et al. 1988) but the reasons for this response are unknown. We speculate that an increase in protein degradation 375 
may have occurred due to increasing altitude exposure (Holm et al. 2010). However, contrary to these changes in 376 
calf girth, an increase in relaxed arm girth was observed between 3619 m and 5140 m. Although this increase was 377 
statistically significant, the absolute increase of 0.3 mm seems trivial. This may represent a compensatory response 378 
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to the significant reduction in arm girth between baseline and 3619 m which is most likely due to atrophy caused 379 
by reduced activity of the arms during final preparations and low altitude trekking. Despite these insights into 380 
changes in body composition, it must be acknowledged that the baseline measures were collected 12 days before 381 
departure from the UK, which may have confounded comparisons between baseline values and those obtained 382 
during the trek due to changes in body composition during the final preparations for the expedition. Potential 383 
increases in lean body mass from final preparations and reductions in body fat would support the observed increase 384 
in body mass at the first fixed camp and reduced skinfold values at all camps relative to baseline. At sea level, an 385 
increase in body mass would usually result in a reduction in acylated ghrelin concentrations (Chen et al. 2009), 386 
which accords with our findings at the first fixed camp. However, in the present study body mass then significantly 387 
reduced at the second and third camps, without a subsequent increase in ghrelin. This suggests that changes in 388 
ghrelin were unlikely to be the result of fluctuations in body mass during the trek and were more strongly mediated 389 
by high altitude exposure.  390 
Although the findings of the present study provide novel information regarding the appetite and 391 
metabolic responses during an incremental trekking ascent to high altitude, some notable limitations must be 392 
acknowledged. First, the current study design did not include a control group to separate the effects of trekking 393 
and high altitude exposure. Therefore it is not possible to conclude that the obtained results are a consequence of 394 
hypobaric hypoxia per se, but are a result of high altitude trekking which combines various environmental and 395 
psychological factors as well as demanding physical exercise. An example of this being that cold exposure may 396 
interfere with energy balance, potentially by increasing non-shivering thermogenesis (van der Lans et al. 2013). 397 
Although this limits interpretation of the influence of each of these factors individually, the study design allowed 398 
us to investigate the effects of a real world gradual ascent to high altitude in order to understand the practical 399 
implications for high altitude trekking. Second, it was not possible to standardise the trekking distance on the day 400 
preceding each fixed camp due to the extreme terrain and environment. The greater trekking distance performed 401 
on the day prior to the final research camp in combination with higher altitude exposure resulted in markedly 402 
higher RPE scores at 5140 m. However, although exercise-induced anorexia occurs acutely in response to 403 
strenuous exercise, tightly controlled laboratory studies suggest that this does not affect appetite perceptions and 404 
ghrelin concentrations during the next day (King et al. 2015). Therefore the suppression of appetite at 5140 m is 405 
unlikely to be due to greater exertion during trekking on the previous day. Furthermore, increased energy 406 
expenditure from the greater trekking distance and the continued suppression of energy intake suggests that 407 
participants would have been in their greatest energy deficit at the final research camp. This would be expected 408 
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to increase appetite under sea level conditions (Alajmi et al. 2016) and provides further support for a genuine 409 
altitude-mediated suppression of appetite. Third, the current study did not assess hydration status during the trek, 410 
therefore it is possible that the observed reduction in body mass could be partly attributed to dehydration. 411 
However, it should be noted that reductions in skinfold and girth measurements were observed during the trek 412 
which suggests that the changes in body mass were at least partly due to genuine reductions in fat mass and muscle 413 
mass. Although the estimation of body composition using skinfold and girth measurements contains limitations, 414 
this was deemed to be the most practical and achievable method of assessment considering the extreme research 415 
environment encountered in the present study. Additionally, mean fluid intake on the day before each fixed camp 416 
was >3.6 L.day-1 which makes it unlikely that the participants experienced severe dehydration. It is not expected 417 
that the higher fluid intake during the trek, compared with baseline, would have influenced the measured ghrelin 418 
constituents given that gastric distension from water ingestion does not appear to influence plasma ghrelin 419 
concentrations (Tschop et al. 2000).  420 
In conclusion, this study represents the first investigation of circulating ghrelin constituents in response 421 
to terrestrial altitude exposure and provides a time course of the changes in appetite, energy intake and body 422 
composition during gradual trekking ascent to high altitude. These findings demonstrate consistently reduced 423 
energy intake during high altitude exposure and an incremental reduction in appetite perceptions with increasing 424 
altitude. These changes were associated with reductions in circulating concentrations of acylated and total ghrelin 425 
during the trek but differences in the time course of these responses suggests that additional factors are also 426 
involved.. A negative energy balance during the trek caused reductions in body mass and lower body muscle mass 427 
which may have negative consequences for physical performance. Future investigations are required to develop 428 
nutritional and/or physiological interventions to maintain appetite, energy intake and muscle mass at altitude.  429 
 430 
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Figure 1 Energy intake (a), palatability score (b) and composite appetite score (c) at baseline, 3619 m, 4600 m 625 
and 5140 m. *significant difference from baseline. ‡significant difference between 4600 m and 5140 m. 626 
§significant difference between 3619 m and 5140 m (One way ANOVA; P < 0.05 after post-hoc analyses). Values 627 
are mean (SE), N = 12 for energy intake and palatability, N = 11 for composite appetite score 628 
 629 
 630 
Figure 2 Acylated ghrelin (a), des-acylated ghrelin (b), AG:DG ratio (c) and total ghrelin (d) concentrations at 631 
baseline, 3619 m, 4600 m and 5140 m. *significant difference from baseline (One way ANOVA; P < 0.05 after 632 
post-hoc analyses). Values are mean (SE), N = 11 633 
  634 
 24 
 
Table 1 Body composition measurements at baseline, 3619 m, 4600 m and 5140 m.  635 
 Baseline 3619 m 4600 m 5140 m 
Body mass (kg) 71.3 (10.3) 73.1 (10.2)* 70.8 (10.7)† 71.1 (10.0)§ 
Sum of 8 Skinfolds (mm) 81.2 (23.7) 74.2 (22.3)* 73.5 (21.7)* 75.5 (23.9)* 
Calf girth (cm) 38.1 (1.9) 37.5 (2.1) 37.2 (2.2)*† 36.9 (2.1)*§ 
Waist girth (cm) 77.5 (6.6) 78.2 (5.5) 77.3 (5.5) 76.6 (5.4)‡§ 
Relaxed arm girth (cm) 29.5 (3.0) 28.6 (3.0)* 28.8 (3.1)* 28.9 (2.9)§ 
Flexed arm girth (cm) 30.6 (3.2) 30.2 (3.2) 30.1 (3.2) 30.1 (3.1) 
Values are mean (SD), N = 12. *significant difference from baseline. †significant difference between 3619 m and 636 
4600 m. ‡significant difference between 4600 m and 5140 m. §significant difference between 3619 m and 5140 m 637 
(One way ANOVA; P < 0.05 after post-hoc analyses) 638 
 639 
